Yahoo · Oct 13, 2026
Steris inks $2.1B Xodus buyout to expand consumables portfolio
The takeover adds high-growth, high-margin products to Steris’ portfolio, analysts said.
NYSE · STE
STERIS plc
Healthcare · Medical - Devices
$225.18
Down-$3.70 (-1.64%)
Updated Oct 22, 2026, 1:05 AM
SID Score
6.2/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 24.83B
- P/E ratio
- 36.07
- Dividend yield
- 1.07%
- 52-week range
- $195.14 – $269.44
- Volume
- 551.05K
- Avg. volume
- 647.87K
Price performance · STE
STE price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 20, 2026
STE closed at $225.18 after 20 trading sessions, up 7.24% for the selected period.
- Last close
- $225.18
- Period change
- +7.24%
- Period low
- $208.54
- Period high
- $225.18
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | $223.99 | $226.63 | $223.28 | $225.18 | 551.05K |
| Oct 19, 2026 | $220.34 | $223.41 | $219.80 | $221.97 | 477.4K |
| Oct 16, 2026 | $225.37 | $226.715 | $221.105 | $222.66 | 601.45K |
| Oct 15, 2026 | $221.81 | $224.51 | $219.00 | $224.33 | 838.58K |
| Oct 14, 2026 | $217.65 | $219.295 | $215.70 | $217.26 | 587.2K |
| Oct 13, 2026 | $220.21 | $221.45 | $216.135 | $217.77 | 509.9K |
| Oct 12, 2026 | $216.09 | $220.745 | $213.77 | $218.98 | 725.95K |
| Oct 9, 2026 | $210.63 | $215.655 | $209.02 | $214.40 | 597.02K |
| Oct 8, 2026 | $209.24 | $210.92 | $207.96 | $210.76 | 498.4K |
| Oct 7, 2026 | $208.66 | $211.95 | $208.37 | $209.68 | 669.84K |
| Oct 6, 2026 | $211.68 | $213.17 | $207.97 | $208.65 | 909.39K |
| Oct 5, 2026 | $208.46 | $213.05 | $207.46 | $211.07 | 804.06K |
| Oct 2, 2026 | $209.64 | $210.27 | $206.53 | $208.54 | 676.53K |
| Oct 1, 2026 | $210.04 | $210.885 | $207.82 | $209.34 | 583.92K |
| Sep 30, 2026 | $210.69 | $212.12 | $209.49 | $210.01 | 560.82K |
| Sep 29, 2026 | $210.05 | $210.77 | $208.07 | $210.65 | 454.33K |
| Sep 28, 2026 | $208.76 | $211.63 | $206.715 | $211.00 | 493.65K |
| Sep 25, 2026 | $208.11 | $209.685 | $207.21 | $208.93 | 447.07K |
| Sep 24, 2026 | $210.05 | $211.45 | $208.57 | $208.77 | 524.38K |
| Sep 23, 2026 | $208.41 | $210.325 | $207.07 | $209.98 | 534.05K |
Latest STE news
The latest Smart Investors Daily articles mentioning STE.
Stock researchCompany · Overview
Company
Market Activity
Research & News
STE research
Overview
Company profile and research snapshot.
Company profile
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $256.67
- Implied upside
- —
- Analysts
- 13
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 7, 2026 | Piper Sandler | Overweight | — |
| Aug 7, 2026 | UBS | Buy | — |
| Jul 28, 2026 | UBS | Buy | — |
| May 13, 2026 | Keybanc | Overweight | — |
| Jul 22, 2025 | Keybanc | Overweight | — |
News briefing
No generated briefing is available yet.
Yahoo · Oct 13, 2026
Steris outlays $2.1bn to acquire Xodus Medical
The takeover is positioned to advance bolster Steris’ portfolio of surgical safety devices – securing access to flagship products like the Pink Pad patient positioning system.
SeekingAlpha · Oct 13, 2026
Steris: Anticipated M&A Has Taken Place, Gets My Thumbs Up
Steris remains a stable, appealing investment, with shares trading at a reasonable 18-19x forward earnings and solid fundamentals.
Yahoo · Oct 12, 2026
Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)
Xodus Medical, a leading developer and manufacturer of innovative surgical safety solutions, today announced that it has entered into an agreement to be acquired by STERIS, a global provider of products and services that support patient care with an emphasis on infection prevention.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
